University Veterinary Hospital, Swedish University of Agricultural Sciences, 750 07 Uppsala, Sweden.
Acta Vet Scand. 2010 Feb 2;52(1):8. doi: 10.1186/1751-0147-52-8.
An in-clinic assay for equine serum amyloid A (SAA) analysis, Equinostic EVA1, was evaluated for use in a clinical setting. Stability of SAA in serum samples was determined.
Intra- and inter- assay variation of the in-clinic method was determined. The in-clinic method (EVA1) results were compared to a reference method (Eiken LZ SAA) with 62 patient samples. For samples with SAA concentrations within the assay range of EVA1 (10-270 mg/L), differences between the methods were evaluated in a difference plot. Linearity under dilution was evaluated in two samples. Stability of SAA in three serum pools stored at 4 degrees C and approximately 22 degrees C was evaluated with the reference method day 0, 1, 2, 4, 7, 17 and analysed with a two-way ANOVA.
The imprecision (coefficient of variation, CV) for the in-clinic method was acceptable at higher SAA concentrations with CV values of 7,3-12%, but poor at low SAA concentrations with CV values of 27% and 37% for intra- and inter-assay variation respectively. Recovery after dilution was 50-138%. The in-clinic assay and the reference method identified equally well horses with low (<10 mg/L) and high (>270 mg/L) SAA concentrations. Within the assay range of the in-clinic method, 10-270 mg/L, the difference between the two methods was slightly higher than could be explained by the inherent imprecision of the assays. There were no significant changes of serum SAA concentrations during storage.
The in-clinic assay identified horses with SAA concentrations of <10 mg/L and >270 mg/L in a similar way as the reference method, and provided an estimate of the SAA concentration in the range of 10-270 mg/L. The imprecision of the in-clinic method was acceptable at high SAA concentrations but not at low concentrations. Dilution of samples gave inconsistent results. SAA was stable both at room temperature and refrigerated, and thus samples may be stored before analysis with the reference method.
本研究旨在评估一种用于临床的马血清淀粉样蛋白 A(SAA)分析的诊所内检测方法——Equinostic EVA1 的性能。本研究测定了血清样本中 SAA 的稳定性。
本研究评估了诊所内检测方法的批内和批间变异度,并比较了 62 份患者样本中诊所内检测方法(EVA1)和参考方法(Eiken LZ SAA)的结果。对于 EVA1 检测范围内(10-270 mg/L)的样本,通过差值图评估两种方法之间的差异。通过对两个稀释样本进行线性评估,确定稀释度下的线性度。使用参考方法,在 4°C 和约 22°C 下分别评估 3 个血清池在储存第 0、1、2、4、7、17 天的 SAA 稳定性,并采用双因素方差分析进行分析。
在较高的 SAA 浓度下,诊所内检测方法的精密度(变异系数,CV)可接受,CV 值分别为 7%、3%-12%,但在较低的 SAA 浓度下,批内和批间变异度的 CV 值分别为 27%和 37%,精密度较差。稀释后回收率为 50%-138%。诊所内检测方法和参考方法对 SAA 浓度较低(<10 mg/L)和较高(>270 mg/L)的马的识别能力相当。在诊所内检测方法的检测范围内(10-270 mg/L),两种方法之间的差异略高于检测方法固有不精密度所能解释的范围。在储存过程中,血清 SAA 浓度无明显变化。
诊所内检测方法可与参考方法类似地识别 SAA 浓度<10 mg/L 和>270 mg/L 的马,并可提供 10-270 mg/L 范围内 SAA 浓度的估计值。在较高的 SAA 浓度下,诊所内检测方法的精密度可接受,但在较低的浓度下则不可接受。稀释样本的结果不一致。SAA 在室温下和冷藏条件下均稳定,因此在使用参考方法进行分析之前,样本可以保存。